Summary
Cerebrovascular disease is a common cause of morbidity and mortality, especially in the elderly. Treatment of hypertension is effective in the primary prevention of stroke. Hypertension is seen in 80% of acute stroke patients but, by the tenth day after admission to hospital, only one-third are still hypertensive.
The clinical significance of post-stroke hypertension is uncertain and its management is a contentious issue. In this article we review current evidence regarding the risks and benefits of the treatment of post-stroke hypertension.
The pathophysiology of post-stroke hypertension is described in relation to autoregulation of cerebral blood flow after cerebral infarction or haemorrhage. In the absence of clinical trial data, recommendations for early treatment of post-stroke hypertension are based on a review of expert opinion that immediate, controlled lowering of blood pressure after acute stroke is required only in defined situations such as hypertensive encephalopathy or aortic dissection. There are no reliable data regarding the comparative effects of different hypotensive agents after acute stroke; short-acting vasodilator drugs are recommended if treatment is essential.
The benefits of hypotensive therapy in secondary prevention of recurrent stroke are uncertain but the results of large clinical trials in progress should provide helpful guidelines for clinical practice.
Similar content being viewed by others
References
Bonita R. Epidemiology of stroke. Lancet 1992; 339: 342–4
MacMahon S, Peto R, Cutler J, et al. Blood pressure, stroke, and coronary heart disease. Part 1. Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet 1990; 335: 765–74
Collins R, Peto R, MacMahon S, et al. Blood pressure, stroke, and coronary heart disease. Part 2. Short term reductions in blood pressure: overview of randomised drug trials in their epidemiological context. Lancet 1990; 335: 827–38
Britton M, Carlsson A, deFaire U. Blood pressure course in patients with acute stroke and matched controls. Stroke 1986; 17: 861–4
Carlberg B, Asplund K, Hagg E. Course of blood pressure in different subsets of patients after acute stroke. Cerebrovasc Dis 1991; 1: 281–7
Harper G, Castleden CM, Potter JF. Factors affecting changes in blood pressure after acute stroke. Stroke 1994; 25: 1726–9
Wallace JD, Levy LL. Blood pressure after stroke. JAMA 1981; 246: 2177–80
Carlberg B, Asplund K, Hagg E. Factors influencing admission blood pressure levels in patients with acute stroke. Stroke 1991; 22: 527–30
Levy DE, Caronna JJ, Lapinski RH, et al. Clinical predictors of recovery from ischaemic stroke. In: Reivich M, Hurtig HL, editors. Cerebrovascular diseases. New York: Raven Press, 1983: 121–8
Feigenson JS, Fletcher H, McDowell FH, et al. Factors influencing outcome and length of stay in a stroke rehabilitation unit. Stroke 1977; 8: 651–7
Henley S, Pettit S, Todd-Pokropek A, et al. Who goes home: predictive factors in stroke recovery. J Neurol Neurosurg Psychiatry 1985; 48: 1–6
Bourestom NC. Predictors of long term recovery in cerebrovascular disease. Arch Phys Med Rehabil 1967; 48: 415–9
Marquarsden J. The natural history of acute cerebrovascular disease: a retrospective study of 769 patients. Acta Neurol Scand 1969; 45 Suppl. 38: 192
Carlberg B, Asplund K, Hagg E. The prognostic value of admission blood pressure in patients with acute stroke. Stroke 1993; 24: 1372–5
Oxbury JM, Greenhail RCD, Grainger KMR. Predicting outcome of stroke: acute stage after cerebral infarction. BMJ 1975; 3: 125–7
Powers WJ. Acute hypertension after stroke: the scientific basis for treatment decisions. Neurology 1993; 43: 461–7
Wollner L, McCarthy ST, Soper NDW, et al. Failure of cerebral autoregulation as a cause of brain dysfunction in the elderly. BMJ 1979; i: 1117–8
Powers WJ. Hemodynamics and metabolism in ischemic cerebrovascular disease. Neurol Clin 1992; 10: 31–48
Paulson OB, Waldemar G, Schmidt JF, et al. Cerebral circulation under normal and pathologic conditions. Am J Cardiol 1989; 63: 2C–5C
Heiss W-D, Graf R. The ischemic penumbra. Curr Opin Neurol 1994; 7: 11–9
O’Connell JE, Gray CS. The stress response to acute stroke. Stress Med 1991; 7: 239–43
Oppenheimer S, Hachinski V. Complications of acute stroke. Lancet 1992; 339: 721–4
Sander D, Klingelhofer J. Changes of circadian blood pressure patterns after hemodynamic and thromboembolic brain infarction. Stroke 1994; 25: 1730–7
Yatsu FM, Zivin J. Hypertension in acute ischaemic strokes: not to treat. Arch Neurol 1985; 42: 999–1000
Spence JD, Del Maestro RF. Hypertension in acute ischaemic strokes. Treat Arch Neurol 1985; 42: 1000–2
Phillips SJ. Pathophysiology and management of hypertension in acute ischemic stroke. Hypertension 1994; 23: 131–6
Britton M, de Faire ULF, Helmers C. Hazards of therapy for excessive hypertension in acute stroke. Acta Med Scand 1980; 207: 253–7
Nunes JP, Faria MDS, Polonia JJ. Acute ischemic stroke during ambulatory blood pressure monitoring. Lancet 1992; 339: 1113–4
Emergency Cardiac Care Committee and Subcommittees, American Heart Association. Guidelines for cardiopulmonary resuscitation and emergency cardiac care. Part IV. special resuscitation situations: stroke. JAMA 1992; 268: 2242–4
O’Connell JE, Gray CS. Treating hypertension after stroke. BMJ 1994; 308: 1523–4
Strandgaard S, Paulson OB. Cerebrovascular consequences of hypertension. Lancet 1994; 344: 519–21
Lavin P. Management of hypertension in patients with acute stroke. Arch Int Med 1986; 146: 66–8
Barer DH, Cruikshank JM, Ebrahim SB, et al. Low dose beta-blockade in acute stroke (‘BEST’ trial): an evaluation. BMJ 1988; 296: 737–41
Trust Study Group. Randomised, double-blind, placebo-controlled trial of nimodipine in acute stroke. Lancet 1990; 336: 1205–9
American Nimodipine Study Group. Clinical trial of nimodipine in acute ischaemic stroke. Stroke 1992; 23: 2–8
Lisk DR, Grotta JC, Lamki LM, et al. Should hypertension be treated after acute stroke? A randomized controlled trial using single photon emission computed tomography. Arch Neurol 1993; 50: 855–62
Calhoun DA, Oparil S. Treatment of hypertensive crisis. N Engl J Med 1990; 323: 1177–83
Hypertensive emergencies [editorial]. Lancet 1991; 338: 220–1
Burn J, Dennis M, Bamford J, et al. Long-term risk of recurrent stroke after a first-ever stroke. The Oxfordshire Community Stroke Project. Stroke 1994; 25: 333–7
Alter M, Friday G, Lai SM, et al. Hypertension and risk of stroke recurrence. Stroke 1994; 25: 1605–10
Irie K, Yamaguchi T, Minematsu K, et al. The J-curve phenomenon in stroke recurrence. Stroke 1993; 24: 1844–9
Hypertension Stroke Co-operative Study Group. Effect of antihypertensive treatment on stroke recurrence. JAMA 1974; 229: 409–18
Carlsson A, Britton M. Blood pressure after stroke. A one-year follow-up study. Stroke 1993; 24: 195–9
Bennet N. Hypertension in the elderly. Lancet 1994; 344: 447–9
Pearce KA, Furberg CD. Hypertensive cardiovascular disease and the treatment of hypertension in the elderly. Curr Opin Nephrol Hypertens 1994; 3: 213–7
SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension: final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA 1991; 265: 3255–64
Bulpitt CJ, Fletcher AE, Amery A, et al. The Hypertension in the Very Elderly Trial (HYVET): rationale, methodology and comparison with previous trials. Drugs Aging 1994; 5: 171–83
Bulpitt CJ, Fletcher AE. Prognostic significance of blood pressure in the very old: implications for the treatment decision. Drugs Aging 1994; 5: 184–91
Bulpitt CJ, Fletcher AE. Compliance with antihypertensive treatment in the elderly In: Amery A, Staesson J, editors. Handbook of hypertension. Vol. 12. Hypertension in the elderly. Amsterdam: Elsevier, 1989: 387–97
Simpson FS. Choice of antihypertensive drugs in the elderly. In: Amery A, Staesson J, editors. Handbook of hypertension. Vol. 12. Hypertension in the elderly. Amsterdam: Elsevier, 1989: 368–86
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
O’Connell, J.E., Gray, C.S. Treatment of Post-Stroke Hypertension. Drugs & Aging 8, 408–415 (1996). https://doi.org/10.2165/00002512-199608060-00002
Published:
Issue Date:
DOI: https://doi.org/10.2165/00002512-199608060-00002